By Jonathan Weiss | May 23, 2013 04:26 PM EDT
New approval of the A1c test will help patients and doctors catch diabetes more easily for speedy treatment.
By Jonathan Weiss | May 23, 2013 02:45 PM EDT
By creating a completely artificial flu-like structure, researchers are on their way to reducing yearly flu shots to just once in a lifetime.
By Jonathan Weiss | May 23, 2013 11:09 AM EDT
Already approved for breast cancer treatment, ABRAXANE has shown promise in increasing survival of advanced pancreatic cancer patients.
By Jonathan Weiss | May 22, 2013 03:57 PM EDT
After a $500 million lawsuit by the US government, the largest stakeholder speaks out.
By Jonathan Weiss | May 22, 2013 02:00 PM EDT
Researchers found 26 genes that were expressed only in patients with aggressive forms of lung cancer, a potential means for earlier detection of the illness.
By Jonathan Weiss | May 22, 2013 02:02 PM EDT
A new finding suggests that hindering a certain destructive enzyme may be the key to treating severe rheumatoid arthritis.
By Jonathan Weiss | May 21, 2013 03:48 PM EDT
Using an inflammation blocking therapy, clinical trials for the new drug have shown extremely positive results in patients with moderate to severe asthma.
By Jonathan Weiss | May 21, 2013 01:51 PM EDT
Because of opposition to vaccines, hundreds of people are now at risk for measles infection.
By Jonathan Weiss | May 21, 2013 11:25 AM EDT
As first responders comb through houses and cars thrown around by gale force winds, there are more dangers to come once survivors are found.
By Jonathan Weiss | May 21, 2013 12:45 AM EDT
Stopped in the middle after a cursory review of data, Pfizer says it won't give up on researching the combination of specific antibody and cell killing agent.
By Jonathan Weiss | May 20, 2013 03:07 PM EDT
New research on reptiles shows that not only do genetics hold the key to limb regeneration, but an important white blood cell of the immune system supports regrowth.
By Jonathan Weiss | May 20, 2013 10:47 AM EDT
A promising sleeping pill, with fewer side effects than current drugs on the market, is in the midst of the FDA approval process.
By Jonathan Weiss | May 20, 2013 10:08 AM EDT
You may not be as protected from cancer and premature skin aging as you think.
By Jonathan Weiss | May 17, 2013 05:18 PM EDT
With the cost of some drugs possibly being reduced by as much as 80 percent, essential medicines will now be more accessible to poorer at-risk communities.
By Jonathan Weiss | May 17, 2013 04:23 PM EDT
The new drug will soon be submitted to the FDA for approval to treat the blood cell proliferative disorder myelofibrosis.